newsfilter
← Latest News
GlobeNewswire·

Albireo to Participate in the H.C. Wainwright Global Investment Conference 2022

BOSTON, May 19, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ:ALBO), a rare liver disease company developing novel bile acid modulators, today announced participation in the H.C. Wainwright Global Life Science Conference May 23-26, 2022. Simon